SKYE · Skye Bioscience, Inc.
$0.42
-0.08 (-16.03%)
At close · Aug 17
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If adequate funds are not available to the Company when needed it will be required to curtail or perhaps cease operations which would, in turn, further raise substantial doubt about its ability to continue as a going concern. These conditions give rise to substantial doubt as to the Company's ability to continue as a going concern within one year after the date that these financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$17.76M
Shares
35.42M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-13 | 23,864 | 614,311 | 638,175 | 68.4% |
| 2026-07-06 | 10,105 | 202,073 | 212,178 | 54.3% |
| 2026-06-29 | 22,881 | 290,128 | 313,009 | 64.7% |
| 2026-06-22 | 25,101 | 314,679 | 339,780 | 58.4% |
| 2026-06-15 | 32,599 | 270,490 | 303,089 | 48.0% |
| 2026-06-08 | 102,904 | 454,284 | 557,188 | 59.6% |
| 2026-06-01 | 54,830 | 637,977 | 692,807 | 61.2% |
| 2026-05-25 | 33,815 | 496,559 | 530,374 | 66.0% |
| 2026-05-18 | 36,263 | 447,041 | 483,304 | 65.3% |
| 2026-05-11 | 52,051 | 477,079 | 529,130 | 55.9% |
| 2026-05-04 | 54,066 | 414,063 | 468,129 | 68.0% |
| 2026-04-27 | 85,748 | 820,150 | 905,898 | 58.9% |
| 2026-04-20 | 106,027 | 520,224 | 626,251 | 62.1% |
| 2026-04-13 | 188,606 | 639,698 | 828,304 | 70.4% |
| 2026-04-06 | 142,259 | 259,051 | 401,310 | 64.7% |
| 2026-03-30 | 31,263 | 583,757 | 615,020 | 58.4% |
| 2026-03-23 | 46,610 | 713,085 | 759,695 | 61.5% |
| 2026-03-16 | 121,284 | 578,595 | 699,879 | 53.9% |
| 2026-03-09 | 589,937 | 9,598,020 | 10,187,957 | 51.3% |
| 2026-03-02 | 82,192 | 483,235 | 565,427 | 66.4% |
| 2026-02-23 | 56,571 | 505,705 | 562,276 | 71.2% |
| 2026-02-16 | 171,545 | 443,763 | 615,308 | 55.3% |
| 2026-02-09 | 60,085 | 865,277 | 925,362 | 59.8% |
| 2026-02-02 | 298,112 | 1,382,188 | 1,680,300 | 62.6% |
| 2026-01-26 | 49,769 | 390,214 | 439,983 | 61.6% |
| 2026-01-19 | 66,203 | 397,741 | 463,944 | 63.6% |
| 2026-01-12 | 236,014 | 814,319 | 1,050,333 | 66.3% |
| 2026-01-05 | 492,429 | 2,006,737 | 2,499,166 | 72.4% |
| 2025-12-29 | 189,388 | 1,589,859 | 1,779,247 | 61.2% |
| 2025-12-22 | 188,610 | 1,800,330 | 1,988,940 | 62.4% |
| 2025-12-15 | 274,282 | 1,153,686 | 1,427,968 | 57.8% |
| 2025-12-08 | 182,797 | 583,151 | 765,948 | 65.7% |
| 2025-12-01 | 161,258 | 743,967 | 905,225 | 63.3% |
| 2025-11-24 | 111,935 | 222,643 | 334,578 | 55.9% |
| 2025-11-17 | 261,453 | 854,423 | 1,115,876 | 61.9% |
| 2025-11-10 | 260,094 | 840,221 | 1,100,315 | 61.0% |
| 2025-11-03 | 183,469 | 584,577 | 768,046 | 59.2% |
| 2025-10-27 | 161,287 | 820,678 | 981,965 | 58.1% |
| 2025-10-20 | 334,840 | 1,960,736 | 2,295,576 | 67.4% |
| 2025-10-13 | 611,934 | 2,142,489 | 2,754,423 | 54.8% |
| 2025-10-06 | 3,006,918 | 12,382,936 | 15,389,854 | 57.0% |
| 2025-09-29 | 224,709 | 1,208,421 | 1,433,130 | 61.3% |
| 2025-09-22 | 262,924 | 1,111,120 | 1,374,044 | 62.3% |
| 2025-09-15 | 147,695 | 840,289 | 987,984 | 54.5% |
| 2025-09-08 | 254,415 | 855,900 | 1,110,315 | 59.6% |
| 2025-09-01 | 162,353 | 730,158 | 892,511 | 59.5% |
| 2025-08-25 | 89,292 | 333,084 | 422,376 | 55.8% |
| 2025-08-18 | 193,295 | 568,713 | 762,008 | 55.7% |
Showing 1–48 of 48 weeks
Key facts
CIK
1516551
CUSIP
83086J200
13F (30d)
43 filings
43 filers
Visit website
Investor relations